Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Quattroflow™ to Feature Single-Use Biologic Pumps at INTERPHEX 2013

Published: Monday, January 28, 2013
Last Updated: Sunday, January 27, 2013
Bookmark and Share
Single-use pumps save time and money, and are quick and easy to change.

Quattroflow™ from Almatec® Maschinenbau GmbH, has announced that it will display the latest offerings in its single-use line of pumps for use in biologic-handling applications within pharmaceutical and biotech operations at INTERPHEX 2013 in Booth No. 2463.

The INTERPHEX show, which brings together a wide variety of leaders from the pharmaceutical industry, will be held from April 23-25, 2013, at the Jacob K. Javits Convention Center in New York, NY, USA.

The incorporation of single-use pumps in biologic-handling applications is gaining wider acceptance among pharmaceutical and biotech manufacturers because they can help optimize end-product speed-to-market.

Single-use, or disposable, pumps feature replaceable wetted pump chamber, which is an advantage for manufacturers looking to maximize their production operations.

Quattroflow positive displacement pumps are ideal for single-use systems because they incorporate a four piston-diaphragm technology with no mechanical seals that is driven by an eccentric shaft and motor.

Quattroflow pumps primarily serve the pharmaceutical and biotech industries in applications that require high containment, purity and cleanability, and are best known for transferring shear-sensitive media of aqueous solutions and biological products without damage, ultimately ensuring product safety, efficiency and reliability.

Quattroflow pumps feature wetted pump chambers made of plastic, while the valves are made of EPDM and the diaphragms of EPDM/PP compound.

The Quattroflow product line consists of four sizes - QF150, QF1200, QF4400, QF5050 and QF20K - with capacities of 1 to 20,000 lph (5283 gph).


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Understanding Female HIV Transmission
Glowing virus maps points of entry through entire female reproductive tract for first time.
Soy Shows Promise as Natural Anti-Microbial Agent
Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses, according to a new study from University of Guelph researchers.
Designing Better Drugs
A rational drug engineering approach could breathe new life into drug development.
AstraZeneca to Sequence 2 Million Genomes in Search for New Drugs
Company launches integrated genomics approach which aims to transform drug discovery and development.
Factors Influencing Influenza Vaccine Effectiveness Uncovered
The long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited, new research suggests.
Study Finds Factors That May Influence Influenza Vaccine Effectiveness
Researchers at NIH have suggested that the long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited.
New Model to Enhance Zika Virus Research
The model will allow researchers to better understand how the virus causes disease and aid in the development of antiviral compounds and vaccines.
Improving Flu Vaccine Effectiveness
NIH study finds factors that may influence influenza vaccine effectiveness.
BMS’s Opdivo Clinical Trial Shows Promise
Safety profile of the combination regimen from CheckMate -069 was consistent with previously reported studies and adverse events were managed using established safety algorithms.
CNS Inflammation: A Pathway and Possible Drug Target
Scientists have long known that the central nervous system (CNS) has a remarkable ability to limit excessive inflammation in the presence of antigens or injury, but how it works has been unclear.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!